Matches in Nanopublications for { ?s ?p "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP282229.RABA-jPDMNEUok7pDpab9jL8FiHX3X8c-IBEf0r30UG_0130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282229.RABA-jPDMNEUok7pDpab9jL8FiHX3X8c-IBEf0r30UG_0130_provenance.
- NP832334.RAubxlXb9mXUlQMDv8nYbSeyCkwdYTz-fdlYWJoRi2mMs130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832334.RAubxlXb9mXUlQMDv8nYbSeyCkwdYTz-fdlYWJoRi2mMs130_provenance.
- NP876845.RAZvza5f5Znewj4RmlfPHgFMmPe9LSm5QHaJ_vEtm62Bo130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876845.RAZvza5f5Znewj4RmlfPHgFMmPe9LSm5QHaJ_vEtm62Bo130_provenance.
- NP957770.RAphb8fOrjyYCU33gTLXaA30OwRFaLnXq1hPj5NT6tm8k130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957770.RAphb8fOrjyYCU33gTLXaA30OwRFaLnXq1hPj5NT6tm8k130_provenance.
- NP921980.RAi7vPmScqCZekI8-0a9ISe6jdyzY6cP5yuiQmuDd7yO4130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921980.RAi7vPmScqCZekI8-0a9ISe6jdyzY6cP5yuiQmuDd7yO4130_provenance.
- NP921962.RAPWLeJ33MmR2HXw4Kz7qLhuZIwlaOPzwMUvK41fjX64s130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921962.RAPWLeJ33MmR2HXw4Kz7qLhuZIwlaOPzwMUvK41fjX64s130_provenance.
- NP876827.RAySPFwet_Cydtg8zn1unkFeDKdkBQahdtYFsvweWKzzE130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876827.RAySPFwet_Cydtg8zn1unkFeDKdkBQahdtYFsvweWKzzE130_provenance.
- NP957745.RA1pSWEeoPO3JtdGggIu9A1mmNxpCsM7QBNZtYGOdtgPw130_assertion description "[We have developed a cancer-specific immunotherapy called modified CTL therapy, which involves adoptive immunotherapy of autologous cancer-specific bulk CTLs after active immunization of autologous or allogeneic cancer cells screened as in vitro stimulators according to their ability to induce autologous cancer-specific CTLs (ACS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957745.RA1pSWEeoPO3JtdGggIu9A1mmNxpCsM7QBNZtYGOdtgPw130_provenance.